A Study to evaluate safety and tolerability of olipudase alfa in pediatric and adult participants with Acid sphingomyelinase deficiency (ASMD) who completed the DFI12712 or the LTS13632 Study in France

Trial Identifier:	PTA17397
Sponsor:	Sanofi
Start Date:	November 2021
Primary Completion Date:	April 2025
Study Completion Date:	April 2025
Condition:	Niemann-Pick disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
FRANCE	BRON, FRANCE, 69500
FRANCE	PARIS, FRANCE, 75020

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.